|
Delayed
London S.E.
19:09:18 30/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 12.60 USD | +1.76% |
|
+3.64% | +54.41% |
| Current month | +5.92% | ||
| 1 month | +5.92% |
Investment objective
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the Index).
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 187.10USD | -8.04% | +542.83% | 7.56% | |
| 288.05USD | +2.51% | -2.47% | 6.29% | |
| 65.95USD | -0.45% | -1.02% | 5.7% | |
| 179.18USD | +0.82% | +74.80% | 4.9% | |
| 278.59USD | +2.42% | +111.87% | 4.84% | |
| 60.64USD | +1.28% | +1.77% | 4.27% | |
| 527.90USD | +0.22% | +16.23% | 4.15% | |
| 426.86USD | +2.98% | +85.90% | 4.05% | |
| 98.16USD | -0.41% | +3.19% | 3.8% | |
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | $12.60 | +1.76% | 3,693 |
| 29/09/26 | $12.39 | -0.45% | 8,999 |
| 28/09/26 | $12.44 | -0.37% | 16,721 |
| 25/09/26 | $12.49 | +2.65% | 10,944 |
| 24/09/26 | $12.17 | +0.03% | 491 |
Description
| IE00BM8R0N95 | |
|---|---|
| Total Expense Ratio | 0.005 |
| Asset Class | Stocks |
| Geographical Zones | |
| Currency | |
| Provider | |
| Underlying | Solactive Genomics v2 Index - USD |
| Autres ETFs | |
Features and characteristics
| Dividend Policy | Capitalisation |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Fund Structure | |
| Date of creation |
04/11/2021
|
AuM evolution - 12/08/2026
| AuM (USD) | 67M |
|---|---|
| AuM 1M | 67M |
| AuM 3 months | 67M |
| AuM 6 months | 67M |
| AuM 12 months | 67M |
- Stock Market
- ETF
- GNOG ETF
Select your edition
All financial news and data tailored to specific country editions
